Meeting Details

  • Date: Friday, September 25, 2026
  • Time: Commenced at 11:31 A.M. (IST) and concluded at 12:02 P.M. (IST)
  • Duration: 31 minutes
  • Location: Conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
  • Deemed Location: Registered Office at 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India
  • Type: Annual General Meeting

Resolutions and Implications

Six resolutions were transacted at the meeting:

1. Ordinary Resolution: To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon.

2. Ordinary Resolution: To appoint Mr. Sanjay Shaileshbhai Majmudar (DIN: 00091305), who retires by rotation as a Director and being eligible, offers himself for re-appointment.

3. Ordinary Resolution: To appoint Mr. Arpit Deepakkumar Shah (DIN: 07214641), who retires by rotation as a Director and being eligible, offers himself for re-appointment.

4. Special Resolution: Appointment of Mr. Viranchi Arvindbhai Shah (DIN: 01598001) as a Non-Executive Independent Director of the Company for a Term of 5 (Five) Consecutive Years.

5. Special Resolution: Approval of 'Senores Pharmaceuticals Employee Stock Option Scheme 2026'.

6. Special Resolution: Approval of Grant of Employee Stock Options to the Employees of the Subsidiary Company(ies) of the Company under 'Senores Pharmaceuticals Employee Stock Option Scheme 2026'.

Voting Process and Methods

The Company provided facility for casting votes through the e-voting system provided by MUFG Intime India Private Limited:

  • Remote e-voting period: Commenced on Tuesday, September 22, 2026 from 09:00 A.M. (IST) onwards and ended on Thursday, September 24, 2026 at 05:00 P.M. (IST)
  • E-voting at AGM: Facility was made available for members who participated in the AGM and had not cast their votes earlier by remote e-voting
  • Extended voting: E-voting facility continued to be available for 15 minutes after conclusion of the meeting (until 12:17 P.M. IST)

Key Voting Outcomes

Detailed voting results as required under Regulation 44(3) of the SEBI LODR Regulations will be submitted separately to the exchanges. The document does not contain specific voting percentages or breakdowns.

Attendance and Participation

Directors and Key Managerial Personnel in Attendance:

  • Mr. Sanjay Shaileshbhai Majmudar (Chairman and Non-Executive, Non-Independent Director)
  • Mr. Swapnil Jatinbhai Shah (Managing Director)
  • Mr. Deval Rajnikant Shah (Whole Time Director and Chief Financial Officer)
  • Mr. Arpit Deepakkumar Shah (Non-Executive, Non-Independent Director)
  • Mr. Jitendra Babulal Sanghvi (Non-Executive, Non-Independent Director)
  • Mr. Kalpit Rajesh Gandhi (Non-Executive, Independent Director)
  • Mr. Udayan Dileep Choksi (Non-Executive, Independent Director)
  • Mr. Naresh Bansilal Shah (Non-Executive, Non-Independent Director)
  • Mr. Ashokkumar Vijaysinh Barot (Non-Executive, Non-Independent Director)
  • Ms. Shilpa Sharma (Company Secretary and Compliance Officer)

Other Attendees:

  • Authorised Representative of M/s Pankaj R. Shah & Associates, Chartered Accountants (Statutory Auditors)
  • Authorised Representative of M/s Sharp and Tannan Associates, Chartered Accountants (Internal Auditors)
  • Mr. Mukesh H. Shah, Proprietor of M/s Mukesh H. Shah & Co. (Secretarial Auditor and Scrutinizer)
  • 49 (Forty Nine) members attended through Video Conferencing including corporate bodies through their representatives

Scrutinizer's Role

Mr. Mukesh H. Shah of M/s Mukesh H. Shah & Co. served as the Scrutinizer for the meeting. The document mentions his attendance but does not provide specific findings or conclusions regarding the voting process.

Additional Information

The proceedings will be made available on the company website at www.senorespharma.com. The meeting included a question and answer session where Mr. Sanjay Shaileshbhai Majmudar, Chairman, answered queries raised by speaker shareholders.